| Press Release

Prof. Yvette van Kooyk Joins United Immunity’s Scientific Advisory Board

United Immunity Co., Ltd., an innovative biotech company developing a Myeloid Targeting Platform™, announced today that Prof. Yvette van Kooyk has joined the company’s scientific advisory board (SAB). PDF

 

Back to Press releases

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.
Accept all Reject Configuration

Website analysis cookies from Google Analytics

Analysis cookies collect information anonymously. This information helps us understand how our visitors use our website. We use the web analytics software Google Analytics for tracking and analysis.

Tracking Cookies

These cookies are used by web analysis tools to collect and analyze usage behavior on our website to improve the website.

Name
Provider
Period of validity
Type
Save and close